Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide

Por Koekkoek, Johan A. F., Dirven, Linda, Heimans, Jan J., Postma, Tjeerd J., Vos, Maaike J., Reijneveld, Jaap C., Taphoorn, Martin J. B.
Publicado no J Neurooncol (2015)

QOL-27 PREVALENCE OF CHANGES IN PERSONALITY AND BEHAVIOR IN ADULT GLIOMA PATIENTS: A SYSTEMATIC REVIEW

Por Zwinkels, Hanneke, Dirven, Linda, Vissers, Thomas, Habets, Esther J.J., Vos, Maaike J., Reijneveld, Jaap C., van den Bent, Martin J., Taphoorn, Martin J.B.
Publicado no Neuro Oncol (2015)

The course of neurocognitive functioning in high-grade glioma patients

Por Bosma, Ingeborg, Vos, Maaike J., Heimans, Jan J., Taphoorn, Martin J.B., Aaronson, Neil K., Postma, Tjeerd J., van der Ploeg, Henk M., Muller, Martin, Vandertop, W. Peter, Slotman, Ben. J., Klein, Martin
Publicado em 2007

Health-related quality of life of long-term high-grade glioma survivors

Por Bosma, Ingeborg, Reijneveld, Jaap C., Douw, Linda, Vos, Maaike J., Postma, Tjeerd J., Aaronson, Neil K., Muller, Martin, Vandertop, W. Peter, Slotman, Ben J., Taphoorn, Martin J. B., Heimans, Jan J., Klein, Martin
Publicado em 2009

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study

Por Koekkoek, Johan A F, Kerkhof, Melissa, Dirven, Linda, Heimans, Jan J, Postma, Tjeerd J, Vos, Maaike J, Bromberg, Jacoline E C, van den Bent, Martin J, Reijneveld, Jaap C, Taphoorn, Martin J B
Publicado no BMC Neurol (2014)